denosumab

English

Etymology

From arbitrary prefix den- + -os- (“bone”) +‎ -umab (“human monoclonal antibody”).

Pronunciation

Noun

denosumab (uncountable)

  1. (pharmacology) A drug (trademarks Prolia and Xgera) that is a genetically engineered monoclonal antibody that reduces bone resorption and increases bone mass by inhibiting osteoclast formation and function and that is administered by injection to prevent fractures associated with osteoporosis and malignant tumors of bone and to treat hypercalcemia associated with various cancers.

References

Indonesian

Noun

denosumab (uncountable)

  1. (pharmacology) denosumab

Further reading

This article is issued from Wiktionary. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.